查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405903

生物样本库市场规模、份额、趋势分析报告：按产品、生物检体类型、生物样本库类型、服务、应用、地区、细分市场预测，2024-2030

Biobank Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

生物样本库市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球生物样本库市场规模预计将达到1,369.1亿美元，预测期内复合年增长率为8.8%。

随着NGS等新技术的引入以及对基因组医学的日益关注，生物样本库不断发展。多种类型的生物样本可用于药物研发、诊断等多个领域，这正在加速生物样本库的多元化并推动市场发展。生物样本的品质对疾病检测以及临床前和临床研究有重大影响。监管机构透过制定有效样本管理指南，在促进生物样本库服务的采用方面发挥重要作用。

例如，美国疾病管制与预防中心 (CDC) 发布了指南，以最大程度地减少处理 COVID-19 样本期间对人类造成的风险。它已成为其他生物样本库的典范。此外，与 COVID-19 相关的研究和临床试验数量的增加预计将在不久的将来显着增加对高品质生物样本的需求，从而导致市场成长。此外，生物检体资料库促进了基于人群的队列研究，以估计实际的血清盛行率。 Health Catalyst, Inc. 透过其 Touchstone 平台提供与 COVID-19 见解相关的国家资料。这些因素预计将有助于该行业的收益。

BioResource 由 RareCan 于 2021 年 10 月创立，RareCan 是一家总部位于赫克瑟姆的医疗保健新兴企业公司，致力于改善型态癌症的研究。 BioResource 保存癌症患者手术后采集的样本，并让世界各地的研究人员可以使用这些样本来治疗、预防和识别疾病。 2021 年 12 月，纽卡斯尔大学推出了新的人体血液样本和人体组织捐赠采集方案。英国生物银行宣布，资料库中增加了测量一系列循环代谢组学生物标记的研究的新资料。 Nightingale Health 是一家专门从事血液生物标记技术的芬兰公司，对 12 万名参与者进行了这项研究。

此外，美国的 COVID-19 病例数量很高，而且研究和开发项目的增加导致了新生物样本库的建立，这推动了北美的收益。随着亚洲国家药品和临床研究领域的不断扩大，预计亚太地区将成为市场成长最快的地区。主要参与者正在努力透过与全球经销商的合作伙伴关係、与其他参与者的併购以及与研究界的策略联盟来扩大其全球影响力。

生物样本库市场报告亮点

  • 由于生物银行库数量不断增加，加上设备高成本，生物样本库设备部门在 2023 年占据最大的收益占有率。
  • 由于这些服务的高普及以及在精准医学和特异性疾病研究的发展中对生物样本储存的需求不断增长，生物样本库和储存库服务生物银行在 2023 年占据了最大的收益占有率。
  • 人体组织是临床研究中保存最完好的样本，导致这种样本类型在市场上占据主导地位。
  • 由于生物医学研究对罕见疾病资料的需求以及对 3D 生物标本的需求不断增长，预计虚拟生物库产业将在预测期内实现最快的复合年增长率。
  • 2023年，由于癌症治疗的细胞疗法日益普及，治疗药物应用领域占据了最大的收益占有率。
  • 一些製药/生物技术公司已经建立了私人银行来支持临床试验和细胞疗法的开发，从而导致该领域的企业收益成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章生物样本库市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 生物样本库市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章生物样本库市场：产品评估与趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球生物样本库市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 生物样本库设备
    • 生物银行耗材
    • 实验室资讯管理系统

第五章生物样本库市场：服务评估与趋势分析

  • 2023年及2030年服务市场占有率
  • 细分仪表板
  • 按服务分類的全球生物样本库市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 生物银行和储存库
    • 实验室加工
    • 资格/检验
    • 低温运输物流
    • 其他服务

第六章生物样本库市场：生物检体类型的估计和趋势分析

  • 2023 年和 2030 年生物检体类型市场占有率
  • 细分仪表板
  • 按生物检体类型分類的全球生物样本库市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 人体组织
    • 人体器官
    • 干细胞
    • 其他生物标本

第七章生物样本库市场：生物样本库类型的估计与趋势分析

  • 生物样本库类型市场占有率，2023 年和 2030 年
  • 细分仪表板
  • 按生物样本库类型分類的全球生物样本库市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 物理/现实生物样本库
    • 虚拟生物样本库

第八章生物样本库市场：应用估算与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 按应用分類的全球生物样本库市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 治疗
    • 药物研发与临床研究
    • 临床诊断
    • 其他用途

第九章生物样本库市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
  • 供应商形势
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023 年主要企业股票分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Qiagen
    • Hamilton Company
    • Tecan Trading AG
    • Danaher Corporation
    • Becton, Dickinson, and Company（BD）
    • Biocision, LLC.
    • Taylor-Wharton
    • Charles River Laboratories
    • Lonza
    • Stemcell Technologies
    • Biovault Family
    • Promocell Gmbh
    • Precision Cellular Storage Ltd.（Virgin Health Bank）
Product Code: GVR-2-68038-564-9

Biobanks Market Growth & Trends:

The global biobanks market size is expected to reach USD 136.91 billion by 2030, registering a CAGR of 8.8% during the forecast period, according to a new report by Grand View Research, Inc. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The 'BioResource' was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights:

  • The biobanking equipment segment accounted for the maximum revenue share in 2023 owing to the high cost of instruments coupled with an increase in the number of biorepositories
  • The biobanking and repository services segment accounted for the largest revenue share in 2023 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
  • Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
  • The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
  • The therapeutics application segment accounted for the largest revenue share in 2023 owing to the growing popularity of cell therapies for cancer treatment
  • Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Service
    • 1.2.3. Biospecimen Type
    • 1.2.4. Biobanks Type
    • 1.2.5. Application
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Service outlook
    • 2.2.3. Biospecimen type outlook
    • 2.2.4. Biobanks type outlook
    • 2.2.5. Application outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
      • 3.2.1.2. Increased focus on precision medicine and genetic testing
      • 3.2.1.3. Changes in biobanking operations
      • 3.2.1.4. Increase in the number of clinical trials globally
      • 3.2.1.5. Growing industry and research collaborations
      • 3.2.1.6. Technology advancement and automation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Disruptions in supply chain management due to COVID-19
      • 3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
      • 3.2.2.3. Sustainability challenges for biobanks
      • 3.2.2.4. Other challenges in biobanking specimens for research
  • 3.3. Biobanks Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Biobanks Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Biobanks Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Biobank Equipment
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Temperature Control Systems
      • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.2. Freezers & Refrigerators
      • 4.4.1.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.3. Cryogenic Storage Systems
      • 4.4.1.2.4. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.5. Thawing Equipment
      • 4.4.1.2.6. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Incubators & Centrifuges
      • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Alarms & Monitoring Systems
      • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Accessories & Other Equipment
      • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Biobanking Consumables
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Laboratory Information Management Systems
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biobanks Market: Service Estimates & Trend Analysis

  • 5.1. Service Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Biobanks Market by Service Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Biobanking & repository
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Lab processing
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Qualification/ Validation
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Cold Chain Logistics
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.5. Other Services
      • 5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biobanks Market: Biospecimen Type Estimates & Trend Analysis

  • 6.1. Biospecimen Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Biobanks Market by Biospecimen Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Human Tissues
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Human Organs
      • 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Stem Cells
      • 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.2. Adult Stem Cells
      • 6.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.3. Embryonic Stem Cells
      • 6.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.4. IPS Cells
      • 6.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.5. Other Stem Cells
      • 6.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Other biospecimens
      • 6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biobanks Market: Biobanks Type Estimates & Trend Analysis

  • 7.1. Biobanks Type Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Biobanks Market by Biobanks Type Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Physical/Real biobanks
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.2. Tissue Biobanks
      • 7.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.3. Population based biobanks
      • 7.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.4. Genetic (DNA/RNA)
      • 7.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.5. Disease based biobanks
      • 7.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Virtual biobanks
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Biobanks Market: Application Estimates & Trend Analysis

  • 8.1. Application Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Biobanks Market by Application Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Therapeutics
      • 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Drug discovery & clinical research
      • 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Clinical Diagnostics
      • 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Other Applications
      • 8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Biobanks Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. Mexico
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework/reimbursement structure
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2023
    • 10.3.4. Thermo Fisher Scientific Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Merck KGaA
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Qiagen
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Hamilton Company
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Tecan Trading AG
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Danaher Corporation
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Becton, Dickinson, and Company (BD)
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Biocision, LLC.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Taylor-Wharton
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Charles River Laboratories
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Lonza
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Stemcell Technologies
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Biovault Family
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Promocell Gmbh
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Precision Cellular Storage Ltd. (Virgin Health Bank)
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 5 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 6 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 7 North America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 10 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 11 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 12 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 15 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 16 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 17 Canada biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 26 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 27 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 28 Germany biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 29 UK biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 31 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 32 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 33 UK biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 34 France biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 35 France biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 36 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 37 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 38 France biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 39 Italy biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 41 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 42 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 43 Italy biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 45 Spain biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 46 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 47 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 48 Spain biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 51 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 52 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 53 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 54 Sweden biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 56 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 57 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 58 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 59 Norway biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 60 Norway biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 61 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 62 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 63 Norway biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 70 China biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 71 China biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 72 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 73 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 74 China biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 75 Japan biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 76 Japan biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 77 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 78 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 79 Japan biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 80 India biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 81 India biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 82 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 83 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 84 India biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Korea biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 87 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 88 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 89 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 90 Australia biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 91 Australia biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 92 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 93 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 94 Australia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 95 Thailand biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 96 Thailand biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 97 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 98 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 99 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 100 Latin America biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 101 Latin America biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 102 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 103 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 104 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 105 Brazil biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 106 Brazil biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 107 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 108 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 109 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 110 Mexico biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 111 Mexico biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 112 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 113 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 114 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 115 Argentina biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 116 Argentina biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 117 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 118 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 119 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 120 MEA biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 121 MEA biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 122 MEA biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 123 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 124 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 125 MEA biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 126 South Africa biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 127 South Africa biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 128 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 129 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 130 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 136 UAE biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 137 UAE biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 138 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 139 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 140 UAE biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 141 Kuwait biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 142 Kuwait biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 143 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Biobanks market: market outlook
  • Fig. 14 Biobanks competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Biobanks market driver impact
  • Fig. 20 Biobanks market restraint impact
  • Fig. 21 Biobanks market strategic initiatives analysis
  • Fig. 22 Biobanks market: Product movement analysis
  • Fig. 23 Biobanks market: Product outlook and key takeaways
  • Fig. 24 Biobanking equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Temperature control systems estimates and forecast, 2018 - 2030
  • Fig. 26 Freezers & refrigerators market estimates and forecast, 2018 - 2030
  • Fig. 27 Cryogenic storage systems market estimates and forecast, 2018 - 2030
  • Fig. 28 Thawing equipment market estimates and forecast, 2018 - 2030
  • Fig. 29 Incubators & centrifuges market estimates and forecast, 2018 - 2030
  • Fig. 30 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Accessories & other equipment market estimates and forecast, 2018 - 2030
  • Fig. 32 Biobanking consumables market estimates and forecast, 2018 - 2030
  • Fig. 33 Laboratory information management systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Biobanks Market: Service movement Analysis
  • Fig. 35 Biobanks market: Service outlook and key takeaways
  • Fig. 36 Biobanking & repository market estimates and forecasts, 2018 - 2030
  • Fig. 37 Lab processing market estimates and forecasts,2018 - 2030
  • Fig. 38 Qualification/ Validation market estimates and forecasts,2018 - 2030
  • Fig. 39 Cold chain logistics market estimates and forecasts, 2018 - 2030
  • Fig. 40 Other services market estimates and forecasts,2018 - 2030
  • Fig. 41 Biobanks market: Biospecimen type movement analysis
  • Fig. 42 Biobanks market: Biospecimen type outlook and key takeaways
  • Fig. 43 Human tissues market estimates and forecasts, 2018 - 2030
  • Fig. 44 Human organs market estimates and forecasts,2018 - 2030
  • Fig. 45 Stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 46 Adult stem cells market estimates and forecasts,2018 - 2030
  • Fig. 47 Embryonic stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 48 IPS cells market estimates and forecasts, 2018 - 2030
  • Fig. 49 Other stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 50 Other biospecimen market estimates and forecasts, 2018 - 2030
  • Fig. 51 Biobanks market: Biobanks type movement analysis
  • Fig. 52 Biobanks market: Biobanks type outlook and key takeaways
  • Fig. 53 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 54 Tissue biobanks market estimates and forecasts,2018 - 2030
  • Fig. 55 Population based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 56 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
  • Fig. 57 Disease based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 58 Virtual biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 59 Biobanks market: Application movement analysis
  • Fig. 60 Biobanks market: Application outlook and key takeaways
  • Fig. 61 Therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 62 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
  • Fig. 63 Clinical diagnostics market estimates and forecasts, 2018 - 2030
  • Fig. 64 Other applications market estimates and forecasts,2018 - 2030
  • Fig. 65 Global biobanks market: Regional movement analysis
  • Fig. 66 Global biobanks market: Regional outlook and key takeaways
  • Fig. 67 Global biobanks market share and leading players
  • Fig. 68 North America market share and leading players
  • Fig. 69 Europe market share and leading players
  • Fig. 70 Asia Pacific market share and leading players
  • Fig. 71 Latin America market share and leading players
  • Fig. 72 Middle East & Africa market share and leading players
  • Fig. 73 North America: SWOT
  • Fig. 74 Europe SWOT
  • Fig. 75 Asia Pacific SWOT
  • Fig. 76 Latin America SWOT
  • Fig. 77 MEA SWOT
  • Fig. 78 North America, by country
  • Fig. 79 North America
  • Fig. 80 North America market estimates and forecasts, 2018 - 2030
  • Fig. 81 U.S.
  • Fig. 82 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 83 Canada
  • Fig. 84 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 85 Europe
  • Fig. 86 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 87 UK
  • Fig. 88 UK market estimates and forecasts, 2018 - 2030
  • Fig. 89 Germany
  • Fig. 90 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 91 France
  • Fig. 92 France market estimates and forecasts, 2018 - 2030
  • Fig. 93 Italy
  • Fig. 94 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 95 Spain
  • Fig. 96 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 97 Denmark
  • Fig. 98 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 99 Sweden
  • Fig. 100 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 101 Norway
  • Fig. 102 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 103 Asia Pacific
  • Fig. 104 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 105 China
  • Fig. 106 China market estimates and forecasts, 2018 - 2030
  • Fig. 107 Japan
  • Fig. 108 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 109 India
  • Fig. 110 India market estimates and forecasts, 2018 - 2030
  • Fig. 111 Thailand
  • Fig. 112 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 113 South Korea
  • Fig. 114 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 115 Australia
  • Fig. 116 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 117 Latin America
  • Fig. 118 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 119 Brazil
  • Fig. 120 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 121 Mexico
  • Fig. 122 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 123 Argentina
  • Fig. 124 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 125 Middle East and Africa
  • Fig. 126 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 127 South Africa
  • Fig. 128 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 129 Saudi Arabia
  • Fig. 130 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 131 UAE
  • Fig. 132 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 133 Kuwait
  • Fig. 134 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 135 Market share of key market players- Biobanks market